Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19

Jennifer L Alejo; Jonathan Mitchell; Amy Chang; Teresa P Y Chiang; Allan B Massie; Dorry L Segev; Martin A Makary

doi:10.1001/jama.2022.1393

Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19

JAMA. 2022 Mar 15;327(11):1085-1087. doi: 10.1001/jama.2022.1393.

Authors

Jennifer L Alejo¹, Jonathan Mitchell¹, Amy Chang¹, Teresa P Y Chiang¹, Allan B Massie¹, Dorry L Segev¹, Martin A Makary¹

Affiliation

¹ Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Abstract

This study uses serologic testing to characterize natural immunity and the long-term durability of SARS-CoV-2 antibodies among unvaccinated US adults by history of COVID-19 infection.

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Adult
Antibodies, Viral / blood*
COVID-19 / blood*
Female
Humans
Male
Middle Aged
SARS-CoV-2 / immunology*
Time Factors
United States
Vaccination

Substances

Antibodies, Viral

Abstract

Publication types

MeSH terms

Substances

Grants and funding